DIALCAT

twitterlinkedin

DIALCAT

Diabetes as an accelerator of cognitive deterioration and Alzheimer’s disease, boarding and adherence

Objective: Prevention of Alzheimer disease in patients with diabetes

The project is based on epidemiological data confirming that patients with diabetes have 2 to 3 times higher prevalence of severe cognitive impairment and Alzheimer’s disease than non-diabetic population comparable in age. To address this reality, the project proposes a comprehensive approach ranging from basic to clinical observational research, and it includes a pilot intervention study.

Innovation: Multidisciplinary and comprehensive approach to treatment intelligence

Expected result: Obtaining an intelligent dispenser prototype and a digital platform integrating data for the identification of risk profiles

Financing: This project has received funding from the European Union through The European Regional Development Funds (ERDF) 

Aquest projecte ha estat cofinançat per la Unió Europea a través del Fons Europeu de Desenvolupament Regional (FEDER).

Objectiu: Promoure el desenvolupament tecnològic, la innovació i una investigació de qualitat.

Project Budget: 2’500’000 €

Financial Framework: RIS3CAT

Contract number: COMRDI15-1-0024-08

Start Date: 15/10/2016

End Date: 30/04/2020

Partners:

Contact Manager: M. Gimenez